INSP - Inspire Medical Systems, Inc.
MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday, November 2. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
INSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, 2028.
Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.
On September 18, 2026, Inspire Medical Systems Inc (INSP) shares rose 5.5% to a current price of $76.78. This price remains significantly below its 52-week high
Hsbc Holdings PLC trimmed its position in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 68.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,241 shares of the company's stock after selling 13,489 shares during
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
Bank of New York Mellon Corp acquired a new stake in Inspire Medical Systems, Inc. (NYSE: INSP) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 148,627 shares of the company's stock, valued at approximately $6,630,000. Bank of New
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.
ADAR1 Capital Management LLC acquired a new stake in Inspire Medical Systems, Inc. (NYSE: INSP) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 374,617 shares of the company's stock, valued at approximately $16,712,000. Inspire Medical Systems accounts for
Bank of America Corp DE cut its holdings in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 11.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 186,069 shares of the company's stock after selling 24,057 shares during the quarter. Bank
Deutsche Bank AG purchased a new stake in shares of Inspire Medical Systems, Inc. (NYSE: INSP) during the undefined quarter, according to the company in its most recent filing with the SEC. The fund purchased 176,200 shares of the company's stock, valued at approximately $7,860,000. Deutsche Bank AG owned about 0.61% of Inspire
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.
Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growth despite coding and reimbursement headwinds.
Medacta Group (OTCMKTS:MEDGF - Get Free Report) and Inspire Medical Systems (NYSE: INSP - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability. Earnings and Valuation This table compares Medacta
ALGT, HMC, INSP, AII and ALL have been added to the Zacks Rank #1 (Strong Buy) List on August 18, 2026.
Assenagon Asset Management S.A. increased its position in Inspire Medical Systems, Inc. (NYSE: INSP) by 66.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 864,395 shares of the company's stock after acquiring an additional 344,221 shares during
Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.